Software or Web Services to Re-Represent Existing Scientific Data and Knowledge into a Knowledge Graph Format
ID: NIH/NIAID 136Type: BOTH
Overview

Topic

Software or Web Services to Re-Represent Existing Scientific Data and Knowledge into a Knowledge Graph Format

Agency

Department of Health and Human ServicesNational Institutes of Health

Program

Type: SBIRPhase: BOTHYear: 2023
Timeline
  1. 1
    Release Aug 25, 2023 12:00 AM
  2. 2
    Open Aug 25, 2023 12:00 AM
  3. 3
    Next Submission Due Nov 14, 2023 12:00 AM
  4. 4
    Close Nov 14, 2023 12:00 AM
Description

The Department of Health and Human Services, specifically the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC), are seeking proposals for Small Business Innovation Research (SBIR) contracts. The solicitation, titled "Software or Web Services to Re-Represent Existing Scientific Data and Knowledge into a Knowledge Graph Format," focuses on the development of software or web services that can convert scientific data and knowledge into a knowledge graph format.

The goal of this research is to address the challenge of digesting and analyzing the increasing volume of scientific data and knowledge. Researchers are increasingly relying on computer algorithms to assist with data analysis and the discovery of new information. The COVID-19 pandemic highlighted the need for efficient data analysis, as a large number of papers were published in a short period of time. The public health response to emerging threats and the treatment of diseases require continuous analysis of new data, which is complicated by the large volume of data being generated.

Knowledge graphs (KGs) have emerged as a valuable technology for data representation and integration. KGs represent information about entities and their relationships in a semantically rich way, enabling efficient data retrieval and analysis by computational algorithms. KGs have shown promise in various scientific domains, such as analyzing collaborations between authors, exploring pathways in molecular biology, and drug repurposing. However, a major bottleneck in leveraging KGs for biomedical research is the difficulty of representing data and knowledge in a KG-compatible format. Many biomedical data are stored in formats that are not compatible with KGs, such as spreadsheets and databases.

The solicitation seeks proposals for the development of software or web services that can convert existing scientific data and knowledge into a KG-compatible format. The funding for this project is as follows: Phase I proposals can receive up to $300,000 for a duration of up to 1 year, while Phase II proposals can receive up to $1.5 million for a duration of up to 3 years. The anticipated number of awards is 1-3.

Overall, this solicitation aims to address the challenge of representing scientific data and knowledge in a KG-compatible format, enabling more efficient data analysis and knowledge discovery in the biomedical research field.

Files
No associated files provided.
Similar Opportunities
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required). This solicitation encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated clinical trials, including mechanistic studies associated with clinical trials. The program supports milestone-driven, hypothesis-driven clinical trials related to the research mission of the NIAID that address high-priority research areas. The solicitation encourages high-risk clinical studies, which involve non-routine interventions, administration of an unlicensed product, or administration of a licensed product for an unapproved indication. Mechanistic studies are also encouraged. The funding supports the conduct, completion, and analysis of a single clinical trial, including activities such as training of study personnel, enrollment and recruitment of study subjects, data collection and management, laboratory work, safety monitoring, and regulatory activities. The project duration is not specified, but the application due dates are provided. More information can be found on the grants.gov website.
Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of novel tools and devices for animal research facilities and to support the care of animal models. The Office of Research Infrastructure Programs (ORIP) is encouraging applications from small business concerns (SBCs) for Small Business Innovation Research (SBIR) projects in this area. The goal of this solicitation is to improve animal welfare, ease the management of individual animals and animal colonies, and enhance the monitoring and control of environmental conditions that affect outcomes and reproducibility in animal model research. The variation of extrinsic factors between different animal facilities has been cited as a source of irreproducibility in animal research, and this solicitation aims to address this issue. The solicitation specifically calls for the development and implementation of novel tools and devices to monitor environmental conditions, identify pathogens and contaminants, and enable noninvasive or minimally invasive monitoring of animal behavior and bodily functions. The devices should be discreet, robust, easy to apply, and mobile. Additionally, the solicitation seeks new software that can combine data from different monitoring devices and be compatible with different data formats. The solicitation emphasizes the importance of innovation and encourages the adaptation of technologies from other fields to improve animal research. It applies to a broad range of animal models, including invertebrate and vertebrate animals, and excludes disease-specific devices, reagents, and experimental protocols. Examples of specific tools and devices that can be developed include portable software for managing and evaluating animal colonies, noninvasive tracking and monitoring technology, automated feeding systems, devices for drug delivery and measurement, improved systems for data collection and analysis, better phenotyping devices, improved holding and transfer devices, and enhanced air and water filters for animal facilities. The solicitation is open for applications until September 6, 2024, and applicants are advised to discuss their projects with the Scientific/Research contacts before submitting an application. More information can be found on the grants.gov website.
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for SBIR Phase IIB Bridge Awards to accelerate the development of cancer-relevant technologies toward commercialization. This funding opportunity aims to support small business concerns (SBCs) that have previously received SBIR or STTR Phase II awards from any Federal agency. The goal is to assist applicants in pursuing the next milestone necessary to advance a promising product or service along a commercialization pathway. The focus is on cancer therapeutics, imaging technologies, diagnostics, prevention and control tools, and model systems for cancer research. The funding will prioritize projects that have secured substantial independent third-party investor funds and those that require approval from a Federal regulatory agency. The application due date is August 21, 2024, and more information can be found at the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-022.html).
Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR) (R43/R44 Clinical Trial Not Allowed)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers through the SBIR program. IDM refers to digital computer-based systems that respond to user actions by presenting content such as text, images, animations, audios, videos, and video games. These resources have been widely used in STEM education to enhance learning experiences. The goal of this solicitation is to develop innovative IDM products that engage users in interactive learning experiences, disseminate knowledge of biomedical science, enhance student interest in the subject, and strengthen problem-solving skills. The products should also focus on developing students' quantitative and computational skills. They can be designed for use inside or outside the classroom, for individual or group settings, with or without teacher or adult participation. Real-time student assessment features are strongly encouraged. The products should be age, grade, and culturally appropriate for the target audience and developed on accessible IDM platforms. The solicitation is open for proposals until September 6, 2025, and more details can be found on the grants.gov and NIH websites.
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development. This program aims to provide additional support for later stage research and development (R&D) and product development not typically supported through Phase II or Phase IIB grants or contracts. The program is designed to bridge the funding gap between the end of the SBIR/STTR Phase II award and the commercialization stage, often referred to as the "Valley of Death." The program supports projects that require technical assistance and R&D studies typically outsourced to contract research organizations (CROs), such as regulatory assistance, IND/IDE enabling studies, toxicology, manufacturing, and clinical trials. The program also supports activities important for commercialization, such as product development, market planning, market research, and costs related to license agreements and partnerships. The program is open to companies that have received Phase II or Phase IIB funding from NIH within the last 36 months. The application due dates are September 5, 2023, January 5, 2024, April 5, 2024, September 5, 2024, January 5, 2025, and April 5, 2025. For more information and to apply, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/PA-files/PAR-23-220.html).